Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
Jason Coppell(Royal Devon and Exeter Hospital), Dietger Niederwieser(Leipzig University of Applied Sciences), Enric Carreras(Josep Carreras Leukaemia Research Institute), Paul G. Richardson(Harvard University), Joseph H. Antin(Dana-Farber Cancer Institute), Eva C. Guinan(Dana-Farber Cancer Institute), Nicole A. Carreau(Dana-Farber Cancer Institute), Robert J. Soiffer(Dana-Farber Cancer Institute), Tiziano Barbui(University of Bergamo), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Massimo Iacobelli(Figli Adottivi e Genitori Naturali), Nancy A. Kernan(Memorial Sloan Kettering Cancer Center), Paul Martin(Duke Medical Center), Allen Chen(Johns Hopkins University), Georgia B. Vogelsang(Johns Hopkins University), Carolyn Revta(Dana-Farber Cancer Institute), Amrita Krishnan(City of Hope), Tapani Ruutu(Helsinki University Hospital)
Cited by 595
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k